Insight Molecular Diagnostics Inc. (0KCC)
LSE
Closed
Aug 25, 2026
Day's Range
4.4152 wk Range
2.45Overview - 0KCC - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
125.17M
EV / EBITDA
‪-3.62‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-3,815.06%‬
Return on Assets
‪-57.82%‬
Ownership
Shares Outstanding
40.66M
Float
10.40M
Held by Insiders
‪20.99%‬
Held by Institutions
‪56.42%‬
Price stats
Beta
‪1.82‬
50-Day Avg
‪1.77‬
200-Day Avg
‪1.77‬
Market Cap - 0KCC - Insight Molecular Diagnostics Inc.
Peers - 0KCC - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0KCCLSEInsight Molecular Diagnostics Inc.174.34MMarket Cap+42.81%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- SHCLSEShaftesbury Capital PLC274.79BMarket Cap+1.80%52-week change7.19P/E (Trailing)‪156.72%‬Profit Margin
- MTOLSEMitie Group plc259.56BMarket Cap+31.35%52-week change34.67P/E (Trailing)‪1.47%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.252.42BMarket Cap+21.99%52-week change0.32P/E (Trailing)‪15.03%‬Profit Margin
- 0R2BLSEDanaher Corporation151.20BMarket Cap+4.13%52-week change0.25P/E (Trailing)‪15.94%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.52.29BMarket Cap+27.10%52-week change0.47P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.48.67BMarket Cap+22.38%52-week change0.39P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - 0KCC - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a precision diagnostics company specializing in the development and commercialization of advanced molecular diagnostic tests for both clinical and research applications. With a core focus on transplant medicine and oncology, the company’s product portfolio includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
